Collaborating Veterinary Clinical Sites Will Provide DentaHeal Investigational Stem Cell Product to Enrolled Patients at No Cost VetCell Therapeutics USA announced today that it has entered the enrollment phase of its DentaHeal™ clinical trial. The company also...
Conducted in collaboration with researchers from the UC Davis School of Veterinary Medicine, this is the first country-wide clinical trial to evaluate the safety, efficacy and potency of VetCell Therapeutics’ feline allogeneic MSC therapy for treating FCGS VetCell...
SANTA ANA, Calif., September 5, 2019–VetCell Therapeutics USA, a pet-focused cell therapy division of PrimeGen Global, Inc., announced today that the company will be presenting multiple presentations at the North American Veterinary Regenerative Medicine Association’s...
It’s not every day you earn a master’s degree, but we’re particularly thrilled for Ana Ramirez, a newly minted Master of Science graduate of Cal Poly Pomona. Ana, now a vet student at Western U, worked on both the clinical and laboratory side of the Canine Atopic...
Last February, we proudly announced the partnership of VetCell Therapeutics and College of Veterinary Medicine at Western University of Health Sciences’ for a preclinical study on the effects of using Mesenchymal Stem Cells (MSC) for treating canine Atopic dermatitis...
